- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 07:12 | Inspira Technologies Oxy GAAP EPS of -$0.14 misses by $0.26, revenue of $1.55M | 2 | Seeking Alpha | ||
| Do | QTREX Quantum Ltd. - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| Do | QTREX Quantum Ltd H1 Loss Declines | 2 | RTTNews | ||
| Do | QTREX Quantum Ltd.: QTREX Quantum Reports First Half 2026 Financial Results | 182 | GlobeNewswire (Europe) | Ness Ziona, Israel, Sept. 24, 2026 (GLOBE NEWSWIRE) -- Record first half revenue of $1.55 million, up 438%, at a 61% gross margin, all generated by the AME and Quantum segment in its first 86 days... ► Artikel lesen | |
| QTREX QUANTUM Aktie jetzt für 0€ handeln | |||||
| 02.09. | QTREX Quantum Ltd.: One of Israel's 3 Largest Defense Companies Begins Immediate Deployment of QTREX Quantum's AME Technology | 2 | GlobeNewswire (USA) | ||
| 31.08. | QTREX Quantum Ltd.: QTREX to Unveil Ultra-High-Density Interconnect Architecture Supporting 17,280 Coaxial Lines per Cryogenic Stage at IEEE Quantum Week 2026 | 4 | GlobeNewswire (USA) | ||
| 28.08. | QTREX Quantum Ltd. - 6-K, Report of foreign issuer | 7 | SEC Filings | ||
| 20.08. | QTREX Quantum nimmt 10 Millionen US-Dollar über Direktplatzierung ein | 6 | Investing.com Deutsch | ||
| 20.08. | QTREX Quantum Ltd.: QTREX Announces Pricing of a $10 Million Registered Direct Offering of Ordinary Shares | 1 | GlobeNewswire (USA) | ||
| 19.08. | QTREX develops laser-printed carbon conductors for quantum chips | 4 | Investing.com | ||
| 19.08. | QTREX Quantum Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 19.08. | QTREX Quantum Ltd.: QTREX's Patent-Pending Technology Achieves First Direct Conversion of 3D-Printed Insulation into Graphene-Like Carbon to Protect Quantum Processors | 1 | GlobeNewswire (USA) | ||
| 03.08. | QTREX Quantum Ltd. - 6-K, Report of foreign issuer | 4 | SEC Filings | ||
| 31.07. | QTREX Quantum Ltd.: QTREX Proprietary Quantum Interconnect Platform Exceeds Performance Requirements Established by Strategic Partners | 3 | GlobeNewswire (USA) | ||
| 27.07. | QTREX Quantum Ltd.: QTREX Launches Quantum Interconnect Research Program with Commercialization Rights to Project-Generated IP | 7 | GlobeNewswire (USA) | ||
| 22.07. | QTREX clarifies F-1 filing relates to existing warrants only | 2 | Investing.com | ||
| 22.07. | QTREX stellt klar: F-1-Einreichung bezieht sich nur auf bestehende Optionsscheine | 5 | Investing.com Deutsch | ||
| 22.07. | QTREX Quantum Ltd.: QTREX Announces Clarification to Registration Statement on Form F-1 | 258 | GlobeNewswire (Europe) | Ness Ziona, Israel, July 22, 2026 (GLOBE NEWSWIRE) -- QTREX Quantum Ltd. (Nasdaq: QTEX) ("QTREX" or the "Company") a company focused on advancing Additively Manufactured Electronics ("AME") for quantum... ► Artikel lesen | |
| 21.07. | QTREX Quantum Ltd. - F-1, Registration statement for certain foreign private issuers | 2 | SEC Filings | ||
| 21.07. | QTREX Quantum Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings |
1 2 3 4 5 Weiter >>
88 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| TELADOC HEALTH | 5,346 | -0,63 % | Teladoc Health, Inc.: Teladoc Health Appoints Financial Executive Mark Anquillare to Its Board of Directors | NEW YORK, Aug. 03, 2026 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in virtual care, today announced the appointment of Mark V. Anquillare to its board of directors. Mr. Anquillare... ► Artikel lesen | |
| SERNOVA BIOTHERAPEUTICS | 0,057 | -11,18 % | Dr. Steven S. Sangha: Steven Sangha Announces Voting and Support Agreement for Sernova Biotherapeutics Inc.'s Proposed Business Combination with Seraxis Holdings, Inc. | Toronto, Ontario--(Newsfile Corp. - September 11, 2026) - Steven Sangha announces he has entered into a voting and support agreement ("Voting Agreement") with Seraxis Holdings, Inc. ("Seraxis") in connection... ► Artikel lesen | |
| CERENOME | 1,554 | -3,84 % | CNSide Diagnostics signs agreement with Blue Cross Michigan | ||
| ATOSSA THERAPEUTICS | 1,790 | -5,29 % | ATOSSA THERAPEUTICS, INC. - 8-K, Current Report | ||
| SONOMA PHARMACEUTICALS | 2,350 | -100,00 % | Sonoma Pharmaceuticals: Historischer Wendepunkt - darum fliegt die Aktie! | Volltreffer: Bereits im Frühjahr hatte ich die positive Entwicklung bei Sonoma Pharmaceuticals antizipiert und die Nano-Cap-Aktie als hochinteressante Turnaround-Spekulation vorgestellt. Damals hatte... ► Artikel lesen | |
| TANDEM DIABETES | 14,400 | 0,00 % | Tandem Diabetes Care, Inc.: Tandem Diabetes Care Launches t:slim X2 Insulin Pump Compatibility with Abbott FreeStyle Libre 3 Plus Sensor in Five International Markets | Compatibility now available in five countries, with additional markets expected throughout 2026.Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company... ► Artikel lesen | |
| CO-DIAGNOSTICS | 1,140 | -0,87 % | Co-Diagnostics Reports Second Quarter 2026 Financial Results | Advancing Commercialization Through FDA Submission, Global Clinical Progress and Manufacturing Expansion
Strengthening Integrated Co-Dx PCR Platform Through Scientific... ► Artikel lesen | |
| QUIDELORTHO | 9,136 | +0,53 % | QuidelOrtho Corp - 8-K, Current Report | ||
| VERU | 2,520 | +0,40 % | Veru Inc.: Veru Reports Fiscal 2026 Third Quarter Financial Results and Phase 2b PLATEAU Clinical Trial Progress | -- Phase 2b PLATEAU clinical trial of enobosarm and semaglutide combination for high quality weight loss is fully enrolled with 239 patients - -- Phase 2b PLATEAU clinical trial interim analysis and... ► Artikel lesen | |
| LIFEWARD | 6,970 | 0,00 % | Lifeward Ltd.: Lifeward Appoints Josh Hexter Interim Chief Executive Officer and Rami Aviram Chief Financial Officer | HUDSON, Mass. and YOKNEAM ILLIT, Israel, Aug. 31, 2026 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) ("Lifeward" or the "Company"), a diversified biomedical innovation company with a portfolio... ► Artikel lesen | |
| CLOVER HEALTH INVESTMENTS | 3,990 | -0,50 % | Clover Health adds two directors to board | ||
| SENSEONICS | 9,250 | +1,65 % | Beta Bionics, Inc.: Beta Bionics Announces Agreement Integrate the iLet Bionic Pancreas and mint with Senseonics' Eversense 365 | IRVINE, Calif., Sept. 22, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced a partnership... ► Artikel lesen | |
| TEMPEST THERAPEUTICS | 0,850 | +0,01 % | Tempest Therapeutics: Tempest Appoints Global Finance Leader Nancy Freda-Smith to Board of Directors | BRISBANE, Calif., Sept. 23, 2026 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST) ("Tempest"), a clinical-stage biotechnology company developing in vivo CAR-T therapies designed to reset... ► Artikel lesen | |
| NANO-X IMAGING | 0,661 | -0,02 % | Nano-X Imaging Ltd: Nanox Expands Latin American Presence with Nanox.ARC Distribution Agreement in Costa Rica | Agreement with SOLME RC, SA Marks the third Latin American market this year PETACH TIKVA, Israel, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Nanox Imaging Ltd. (NASDAQ: NNOX) ("Nanox"), a leader in innovative... ► Artikel lesen | |
| IMUNON | 1,180 | 0,00 % | Imunon presents Phase 2 ovarian cancer survival data at R&D day |
Das Unternehmen QTREX QUANTUM LTD kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell +0,21 % bei einem Aktienkurs von 0,762 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu QTREX QUANTUM LTD finden Sie auf Wallstreet Online.